Actively Recruiting
Different Medications to Induce Labor
Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-03-31
300
Participants Needed
2
Research Sites
99 weeks
Total Duration
On this page
Sponsors
I
Icahn School of Medicine at Mount Sinai
Lead Sponsor
B
Bronx Care Health System
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
CONDITIONS
Official Title
Different Medications to Induce Labor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant patient presenting to labor & delivery for induction of labor with a BMI >= 30
You will not qualify if you...
- Pregnant patient presenting to labor & delivery for induction of labor with BMI < 30
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Mount Sinai Hospital
New York, New York, United States, 10029
Actively Recruiting
2
Bronx Care Health System
The Bronx, New York, United States, 10457
Actively Recruiting
Research Team
N
Nicola F Tavella, MPH
CONTACT
A
Allison Perelman, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here